Skip to main content


  • Wednesday, Jun 19th
    3:30 PM – 3:45 PM PT
    Inferring Disease Mechanisms in Lupus Nephritis: lessons from the Accelerating Medicines Partnership (AMP) in SLE Consortium
    Location: Salon 8
    Presenting Author: Arnon Arazi, PhD – The Feinstein Institutes for Medical Research
    Autoimmune Diseases
  • Wednesday, Jun 19th
    4:15 PM – 4:30 PM PT
    A Novel Exosite Inhibitor that Selectively Reprograms TBK1-STING Pathway for Autoimmune Diseases
    Location: Salons 3-6
    Presenting Author: Bhavatarini Vangamudi, PhD – Exo Therapeutics
    Autoimmune Diseases
  • Wednesday, Jun 19th
    4:15 PM – 4:30 PM PT
    Pharmacodynamic Demonstration of Immunological Tolerance Induced by KAN-101, a Novel Liver-targeted Therapy for Celiac Disease
    Location: Salon 8
    Presenting Author: Kristie M. Grebe, PhD – Anokion
    Autoimmune Diseases
  • Wednesday, Jun 19th
    4:30 PM – 4:45 PM PT
    Single Cell Analysis of CD8 T-cells Reveals Autoantigen Specific Signatures of Teplizumab Treatment in at Risk Subjects from the trialnet-10 Study
    Location: Salon 8
    Presenting Author: Hai T. Nguyen, PhD – Benaroya Research Institute
    Autoimmune Diseases
  • Wednesday, Jun 19th
    4:45 PM – 5:00 PM PT
    BiTEing Multi-drug Resistant Rheumatoid Arthritis with CD19-T Cell Engagers
    Location: Salon 8
    Presenting Author: Ricardo Grieshaber-Bouyer, MD – Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen
    Autoimmune Diseases
  • Thursday, Jun 20th
    4:45 PM – 5:00 PM PT
    Expanding Our Understanding of PDC-E2 T Cell Responses in PBC and Their Application for Eng Treg Therapy
    Location: Salon 7
    Presenting Author: Ritika Tewari, PhD – Benaroya Research Institute
    Autoimmune Diseases